US Inflation Forecasts Marked Higher for 2023, Survey Shows

(Bloomberg) — Economists boosted their inflation estimates for each quarter in 2023, a potentially worrying sign for Federal Reserve policymakers trying to keep price expectations anchored.

The personal consumption expenditures index, which the Fed uses for its inflation target, is seen averaging an annualized 2.5% at the end of next year, up from 2.3% in July, the latest Bloomberg monthly survey showed.

Perhaps a more troubling sign of the broad-based nature of inflationary pressures, economists project the year-over-year core PCE price gauge, which strips out volatile food and energy costs, to average 2.9% in the fourth quarter of next year, up from last month’s 2.6%.

The higher inflation projections could be a concerning development for the Fed, which has already stepped up the magnitude of its interest-rate hikes to curb price pressures. Should the forecasts come to fruition, that might mean the central bank will have to do even more to achieve its 2% inflation goal.

The Fed also closely monitors inflation expectations since they risk becoming a self-fulfilling prophecy. Consumers expecting higher prices may spend more now, keeping demand elevated and further testing the productive capacity of the economy. Businesses, which are already experiencing higher labor costs, may respond by raising prices further.

The 56 economists, who were surveyed from Aug. 5-10, also see the consumer price index clocking in higher throughout next year than they did a month ago. Most of their responses were recorded before the July CPI released on Wednesday and the producer price index on Thursday, both of which moderated on the heels of cheaper energy prices.

Meantime, the probability of a recession over the next 12 months now stands at 49%, up from 47.5% in the July survey, according to 35 of the economists who responded.

Gross domestic product is seen rising an average 1.1% next year, slower than the 1.3% projected last month. GDP growth isn’t expected to top 1.4% in any quarter in 2023.

 

More stories like this are available on bloomberg.com

©2022 Bloomberg L.P.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More